INSIGHTS ON DRUG DEVELOPMENT
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
Revolutionizing The Development, Characterization, And Manufacturing Of Peptides
Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.
-
The Top Tech Transfer Risks At Multi-Site CDMOs
Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering7/31/2025
Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.
-
Why Reshoring Is An Essential Strategy For ADC Supply Chain Security2/24/2026
Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.
-
Rapid Automated Selection Of Mammalian Cell Colonies3/17/2025
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
-
Characterizing Binding Interactions By ITC4/24/2025
Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.
-
Developing A Quantitative Surrogate Peptide Assay7/17/2025
Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.
DRUG DEVELOPMENT SOLUTIONS
-
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
-
Discover purpose-built lab tools that combine intuitive design, dependable performance, and accessible cost to support fast, confident scientific work.
-
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
-
Precise optics, fluidic transfer, and assay flexibility on one integrated microplate reader.